Active-ingredient Dossier
Duloxetine Hydrochloride
Active-ingredient Dossier for Duloxetine Hydrochloride (serotonin norepinephrine reuptake inhibitor). Australian brands, products, PBS listings, PBAC…
- Brand: APO-DULOXETINE
- Brand: DULOXECOR
- Brand: DULOXETINE-WGR
- Brand: DYTREX
- Brand: TIXOL
- Brand: DULOCYM
- Therapeutic area: Psychiatry
What is
Duloxetine Hydrochloride Duloxetine Hydrochloride is a serotonin norepinephrine reuptake inhibitor. It is registered in Australia across 17 brands on the ARTG.
Australian brands containing
Duloxetine Hydrochloride The following brands contain duloxetine hydrochloride: — APO-DULOXETINE — DULOXECOR — DEPRETA — DULOXETINE — DULOXETINE SANDOZ — DULOXETINE-WGR — DYTREX — TIXOL
Therapeutic areas
Duloxetine hydrochloride is registered in Pain & Anaesthesia (10 brands), Neurology (6 brands), and Psychiatry (1 brand).
Sponsor landscape
The ingredient is marketed by eight sponsors: Arrotex Pharmaceuticals, Alembic Pharmaceuticals, Strides Pharma Science, Pharmacor, Lupin, and Sandoz.
PBS and regulatory activity
One brand containing duloxetine hydrochloride has PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 March 2008, and no AusPARs are currently on record for this ingredient.